Aadi Bioscience Valuation
| AADI Stock | USD 2.22 0.08 3.48% |
Based on Macroaxis valuation methodology, the firm appears to be undervalued. Aadi Bioscience shows a prevailing Real Value of $10.55 per share. The current price of the firm is $2.22. Our model approximates the value of Aadi Bioscience from analyzing the firm fundamentals such as profit margin of (2.46) %, and Return On Equity of -0.66 as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Aadi Bioscience's valuation include:
Price Book 0.8232 | Enterprise Value -5 M | Enterprise Value Ebitda (0.62) | Price Sales 2.2612 | Enterprise Value Revenue 3.4826 |
Undervalued
Today
Please note that Aadi Bioscience's price fluctuation is somewhat reliable at this time. Calculation of the real value of Aadi Bioscience is based on 3 months time horizon. Increasing Aadi Bioscience's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Aadi Bioscience is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Aadi Stock. However, Aadi Bioscience's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.22 | Real 10.55 | Target 35.25 | Hype 2.21 | Naive 2.29 |
The intrinsic value of Aadi Bioscience's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Aadi Bioscience's stock price.
Estimating the potential upside or downside of Aadi Bioscience helps investors to forecast how Aadi stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Aadi Bioscience more accurately as focusing exclusively on Aadi Bioscience's fundamentals will not take into account other important factors: When choosing an evaluation method for Aadi Bioscience, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using all methods to arrive at a better estimate.
Aadi Bioscience Cash |
|
Aadi Valuation Trend
Aadi Bioscience's real value analysis enables investors to forecast the earnings more efficiently. Using both Aadi Bioscience's enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing decisions.
Aadi Bioscience Total Value Analysis
Aadi Bioscience is presently forecasted to have valuation of (4.98 M) with market capitalization of 56.69 M, debt of 1.27 M, and cash on hands of 118.74 M. The negative valuation of Aadi Bioscience may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should vigilantly validate all of the Aadi Bioscience fundamentals.| Takeover Price | Market Cap | Debt Obligations | Cash |
(4.98 M) | 56.69 M | 1.27 M | 118.74 M |
Aadi Bioscience Investor Information
About 49.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.82. Some equities with similar Price to Book (P/B) outperform the market in the long run. Aadi Bioscience recorded a loss per share of 2.28. The entity had not issued any dividends in recent years. The firm had 1:15 split on the 27th of August 2021. Based on the measurements of operating efficiency obtained from Aadi Bioscience's historical financial statements, Aadi Bioscience is not in a good financial situation at this time. It has a very high odds of going through financial crisis in December.Aadi Bioscience Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Aadi Bioscience has an asset utilization ratio of 18.39 percent. This signifies that the Company is making $0.18 for each dollar of assets. An increasing asset utilization means that Aadi Bioscience is more efficient with each dollar of assets it utilizes for everyday operations.Aadi Bioscience Ownership Allocation
Aadi Bioscience holds a total of 24.65 Million outstanding shares. 30% of Aadi Bioscience outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Aadi Bioscience Profitability Analysis
The company reported the previous year's revenue of 24.35 M. Net Loss for the year was (65.77 M) with loss before overhead, payroll, taxes, and interest of (18.78 M).About Aadi Bioscience Valuation
An absolute valuation paradigm, as applied to Aadi Stock, attempts to find the value of Aadi Bioscience based on its fundamental and basic technical indicators. By analyzing Aadi Bioscience's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Aadi Bioscience's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Aadi Bioscience. We calculate exposure to Aadi Bioscience's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Aadi Bioscience's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 21.5 M | 22.6 M | |
| Pretax Profit Margin | (2.70) | (2.84) | |
| Operating Profit Margin | (2.95) | (3.10) | |
| Net Loss | (2.70) | (2.84) | |
| Gross Profit Margin | 0.88 | 0.97 |
Aadi Bioscience Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 26.9 M |
Aadi Bioscience Current Valuation Indicators
Valuation refers to the process of determining the present value of Aadi Bioscience and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Aadi we look at many different elements of the entity such as Aadi's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Aadi Bioscience, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Aadi Bioscience's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Aadi Bioscience's worth.Complementary Tools for Aadi Stock analysis
When running Aadi Bioscience's price analysis, check to measure Aadi Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aadi Bioscience is operating at the current time. Most of Aadi Bioscience's value examination focuses on studying past and present price action to predict the probability of Aadi Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aadi Bioscience's price. Additionally, you may evaluate how the addition of Aadi Bioscience to your portfolios can decrease your overall portfolio volatility.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |